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ABSTRACT 
Certain techniques are used for the preparation of solid dispersions and used to enhance the solubility of water insoluble drugs. One 
of its techniques is supercritical fluid technology that is used for the preparation of solid dispersions. The present aim of this 
technique is to provide the recent advances in the use of supercritical fluids for the preparation of solid dispersion and for 
pharmaceutical substances with particular attention to drug delivery systems. Basically a “supercritical fluid” can be defined as it 
enters in the pure substance when both temp. & pressure above its critical P&T. In the SCF techniques there are certain solvents like 
CO2, N2O used as supercritical fluid. This innovative technique is highly promising and approachable for the future applications in 
pharmaceutical industries. 
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INTRODUCTION 
There are number of approaches can be used to enhance 
the solubility of poorly soluble drugs such as Solid 
dispersion
1
, hydration, Nanosuspension
2
, lipid based 
drug delivery systems
3
 and Cocrystalization
4
. Apart 
from available approaches of supercritical fluid 
technology is an emerging alternative approach for 
enhancement of solubility of such drugs. 
In the pharmaceutical field, early 1980s; Supercritical 
fluid technology was applied for industrial applications 
in the same period. This is a recent technique that 
produces fine drug particles and becomes more valuable 
for product quality, batch consistency and useful for the 
pharmaceutical applications. The progress in this 
technology is based on multidisciplinary approach and a 
considerable progress has been made over the last 
decade in the application of supercritical fluids (SCFs) 
to the processing of pharmaceuticals
5,6
 and to the 
preparation of drug delivery systems
7, 8
. The use of SCFs 
for the preparation and control of the specific physical 
form of pharmaceutical substances relevant to those 
fluids used for drug delivery systems have been 
described
9, 10
. SCFs are also having various applications 
in the food industry and pharmaceutical industry 
especially in the drug delivery system designs that 
becomes more recent technique for the future 
perspectives of pharmaceutical applications.  Basically 
the original concept of supercritical fluids as becomes 
“green” alternative approach and very important as the 
regulatory requirements and residual contents of volatile 
solvents in the drug products that becomes more 
restrictive. 
Supercritical fluids: 
Critical temperature: The critical temperature of a 
supercritical fluid may be defined as, at highest 
temperature of the gas which can be liquefied by raising 
the pressure of the system. 
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Critical pressure: The critical pressure of supercritical 
fluid may be defined as, at highest pressure a liquid 
becomes converted to the gas by raising the temperature 
of the system. 
A supercritical fluid can defined as any substance at a 
temp. & pressure above its critical point where the liquid 
and gas phase can co exist and at this stage it is called 
Supercritical fluid, while this technique utilizing these 
fluids, then it is called as Supercritical fluid technology
9
. 
In this region, the SCF exists as in an intermediate phase 
between liquid and gas phases
9
. The typical operating 
conditions for critical temperature and pressure for 
supercritical fluids are 1.01(Tc) to 1.1(Tc) and 1.01(Pc) 
to 1.1(Pc), respectively.  At this critical point only a 
single phase can exist which has some typical properties 
of liquids and gases (viscosity, compressibility and 
diffusion coefficient).  
Advantages of supercritical fluid technology and 
becomes more effective over other techniques are
11
: 
1. Supercritical fluids are highly versatile & flexible. 
2. Supercritical fluids are used with the less amount of 
organic solvents ability to reach the desired conditions 
(change in pressure& the rate of solvent evaporation). 
3. This processes shows high compressibility 
&diffusivity of the supercritical fluids. 
4. Supercritical fluid technology is used to enhance the 
selectivity and yield by adjusting the solvent strength.  
5. SCF has High diffusion coefficient and low viscosity. 
6. Good environment compatibility and non toxicity of 
the solvents. 
Certain commonly used supercritical solvents are: 
carbon dioxide, nitrous oxide, ethylene, propylene, 
propane, n-pentane, ethanol, ammonia, and water. 
Carbon dioxide is most commonly used because it has 
low critical temperature (Tc = 31.10C) and pressure (Pc 
= 73.8 bar) and becomes more advantageous i.e. 
nontoxic, non-flammable, and inexpensive, and low 
critical temperatures
14
.This process is useful for 
processing of heat labile molecules by proper 
adjustments of operating conditions as well as physical 
and chemical parameters (pressure, temperature, drug 
concentration, flow and nature of supercritical fluid and 
organic solvents) 
9
. 
 
Some common Supercritical solvents used in the industry are
12
: 
 
 
 
 
 
 
 
Supercritical fluids are also having moderate to high density around the supercritical region also shows high 
compressibility. Even, if it shows slight variation in the applied pressure then it may causes alteration in its density and 
solvency of the organic solvent. The solvency power of the supercritical fluids that compares with gases and liquids on 
the basis of their density and viscosity
11, 13
. 
Properties of Supercritical Fluid that compares with Gas & water on the basis of their density and viscosity
11
 
Phase of the 
Solvent 
Density 
(gm/ml) 
Viscosity 
(gm.cm-1 sec-1) 
Coefficient of 
diffusion 
Comparison 
Super critical Fluid 0.1 to 1.0 0.0001 to 0.001 0.001 to 0.0001 Viscosity is similar to gas. 
Gaseous 0.001 0.0001 0.1 Viscosity is similar to supercritical 
fluid 
Liquid 1.0 0.01 Less than 0.00001 Viscosity is greater than Gas and 
supercritical fluid 
 
General phase diagram of super critical fluid region: 
If any fluid said to be entered in the supercritical phase 
region, at which both pressure and temperature crosses 
its critical pressure and temperature values, during these 
conditions, the Supercritical fluid depicts its existence in 
an intermediate phase between gaseous and liquid 
phases respectively
14
. 
 
 
Solvent Critical Pressure (Atm) Critical temperature (K) Density (mg/ml) 
H2O 218 647 320 
CO2 73 304 470 
C2H5OH 63 517 280 
C6H6 48 562 300 
NH3 113 406 240 
C2H6 48 306 600 
CHCl3 28 209 340 
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Classification of supercritical fluids
11
: 
1. Technologies using SCF as a Solvent: 
 RESS (Rapid Expansion of Supercritical Solution). 
 RESOLV (Rapid Expansion Using SCF As A 
Solvent Into A Liquid Solvent) 
2. Technologies using SCF as an anti-solvent: 
 GAS(Gaseous Anti-solvent) 
 PCA (Particles by Compressed Anti-solvent), SAS 
(Supercritical Anti-solvent), ASES (Aerosol Solvent 
Extraction System). 
 SEDS (Solution Enhanced Dispersion into a liquid 
Solvent. 
Some technologies used in the Supercritical Fluid 
technology: In Super critical fluid technology, it 
becomes possible: 
 To reduce the size of the particle. 
 The content of the residue of the solvent in single 
step and control the various parameters related to 
the particle characteristics like particle size 
distribution, polymorphism, crystal lattice and 
morphology. 
We can classify the processes in two groups as 
depending on the use of the supercritical fluid in the 
system: 
A.) Solvent 
B.) Anti-solvent. 
Technologies using SCF as a solvent: 
1. RESS (Rapid expansion of a supercritical 
solution): 
This technology was firstly recorded by Hannay and 
Hogarth
9
 
 Simple process. 
 Supercritical fluid is used as a crystallization 
solvent. 
 Solution is rapidly expanded by sudden 
decompression passing through an orifice at 
reduced pressure. 
When the solid is dissolved in the gas and then the solid 
is precipitated by reducing the pressure then it becomes 
brought as a snow in the gas. Firstly this concept is 
applied to produce fine particles with narrow range size 
distribution using SCF technology and this technique 
called as rapid expansion of a supercritical solution 
(RESS)
15
. Generally this process requires mainly 
consisting of preheated, solubilization vessel and 
precipitator. Firstly the heated gas becomes pressurized 
that containing solute and pumped into solubilization 
unit. Supercritical fluid dissolves solute is passed 
through heated nozzle, and then that solution becomes 
rapidly expanded at supersonic speed. Rapid expansion 
of supercritical solution in which both density and 
solvent power decreases it leads to solute 
supersaturating. The main advantage of RESS technique 
that produces the production of small particles with 
uniform size
16
. 
 
Figure 1: RESS (Rapid Expansion of Supercritical 
Solution) 
2. RESOLV (Rapid expansion of a supercritical 
solution into liquid solvent): 
Firstly the solution of the drug is dissolved in the liquid 
carbon dioxide inside a high-pressure syringe pump and 
the solution is pumped into a heating unit to attain the 
desired temperature conditions before expansion through 
a laser–drilled orifice and rapid solution occurs into the 
aqueous medium at ambient temperature
9, 17
. 
Technologies using SCF as an anti-solvent: 
The supercritical fluid used as anti-solvent that comes in 
contact with the solute dissolved in a suitable organic 
solvent. 
Precipitation using SCF as an anti-solvent: 
 A liquid solubilizes to a large amount of gaseous 
carbon dioxide. 
 Anti-solvent should have the low affinity for the 
solute but least partial miscibility with the organic 
phase. 
 Nucleation and the consequent growth of crystals 
from the solute /organic/anti-solvent system is 
governed by: 
1. The diffusion of the anti-solvent into the organic 
phase. 
2. The evaporation of the organic solvent into the anti-
solvent Phase
9
. 
Different experimental designs of the anti-solvent 
processes which can be classified on the basis of 
different mixing modes between the solution and the 
SCF are: 
1. GAS (Gaseous Anti-solvent): 
Advantages: 
The main advantages of this technique are to be 
introduced the SCF through the bottom of the vessel 
when a mixing of good solvent and anti-solvent can be 
obtained
9
. 
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 It is a technique that involves the gradual 
introduction of carbon dioxide inside a vessel filled 
with the solute solution. 
 The carbon dioxide is pumped into the vessel till the 
fixed pressure is attained. 
2. PCA (particles by compressed anti-solvent), 
SAS (Supercritical Anti-solvent), ASES (Aerosol 
Solvent Extraction System): 
 In these three technologies the carbon dioxide used 
as supercritical fluid for SAS or PCA is firstly 
pumped into the high pressure vessel until the 
system reaches the desired conditions at that 
temperature and pressure. Then the organic solution 
is sprayed through nozzle into the SCF bulk and the 
particles are collected on a filter at the bottom of 
vessel. 
ASES (Aerosol Solvent Extraction System): 
It represents the modification implying the simultaneous 
spraying of the solution and anti-solvent. 
SEDS (Solution Enhanced Dispersion by 
Supercritical Solvent): 
It is an innovative technique developed by HANNA 
& YORK
18
. 
 In this process the drug solution and the 
supercritical fluids are introduced simultaneously 
into the particle formation vessel through the 
mixing chamber of a co-axial nozzle. 
 The use of the mixing chamber favors the higher 
mixing surface area that may leads to the increase 
the mass transfer. Then higher the mass transfer 
causes: 
        1. A fast nucleation rate. 
        2. The particles are formed of small size with little 
aggregation. 
These are highly controlled, reproducible Technique as 
compared to another anti-solvent SCF processes and 
proved to be a suitable for scaling up and manufacturing 
according to the GMP requirements
19
. 
 
Certain examples of Pharmaceutical compounds micronized and converted in amorphous form using SCF based 
techniques. 
 
Applications of the Supercritical fluids technology: 
1.  Use of Micronization of the drugs:  
The Supercritical anti-solvent technique has been 
successfully used for the particle size reduction of 
the drugs having low solubility in the supercritical 
fluid, like trypsin, catalase, methyl etc. Some of 
Drugs which have been    micronized by using 
Supercritical fluid techniques 5- Fluorouracil, 
Lysozyme, Atorvastatin Calcium, Cyclosporine A. 
2. Enhancement of solubility of the drugs: 
Supercritical fluid technology, Especially Rapid 
expansion on supercritical solution technique has 
been used for the improvement of the solubility of 
water insoluble drugs.  Some examples of drugs 
processed to enhance solubility of water insoluble 
drugs.
20
 Atenolol Aerosol based solvent extraction 
system, Phenytoin Gaseous anti-solvent 
crystallization, Felodipine Supercritical anti solvent 
system, Naproxen Rapid expansion Supercritical 
solution. 
3.  Use of SCF technology in Solid dispersion: 
It provides the advantage for the preparation of 
solid dispersion dosage form free of the organic 
solvent in order to enhance the solubility of the 
poorly soluble drugs having poor solubility e.g. A 
PEG 4000 based solid dispersion of carbamazepine 
in order to enhance the dissolution rate and extent
21
. 
4. Drying at various stages in the Pharmaceutical 
operations:  
Drying is the process of the removal of solvent from 
the bulk mass, which has to be achieved at different 
phases in the development and production of a 
pharmaceutical product. Supercritical drying 
provides the benefits of removal of the solvent 
without appearance of the distortion and shrinkage 
in the solid particle that arise due to the effects of 
surface tension. Technique is being used in the 
production of the “Aero gel” (material having 
lowest bulk density of porous solid) and drying of 
the delicate materials as biological samples for 
electron microscopy
11
.  
FUTURE PROSPECTS  
The focus of this technique that should be drawn on 
exploring the application of the supercritical fluid 
technology and to find the other potential prospects that 
can effect on Supercritical fluid as defined in the critical 
temperature and pressure conditions, while reduction in 
the expenditure of the scale up that should also be 
considered, in order to improve the acceptability of this 
technique in the small as well as large industrial 
applications. 
 
drug used  Method  Observations and Conclusion Reference  
5 fluorouracil  SEDS  Increases in the solubility as spherical particles are formed.   Chen A. et al., 2006  
amoxicillin  SAS  Amorphous spherical particles of 0.2-1.6 μm.   Kalogiannis C. e tal., 2005  
Lysozyme  GAS  Amorphous spherical particles, more or less agglomerated 
200-300 nm.  
 Muhrer G. et al., 2003 
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CONCLUSIONS 
SCF based technology currently valid tools to control 
the crystal form of pharmaceuticals. It is clear that by 
appropriate regulation of the working conditions 
specific crystal form a material can be produced, so 
investigation of the effects of these factors that affects 
the various characteristics of the particle still deserves a 
respectful approach, which should be focused on the 
particle kinetics and thermodynamics leading the 
occurrence of the precipitation from the supercritical 
fluid. Supercritical fluid technology have found unique 
applications in the production and processing of drug 
particles and is now considered to be an innovative and 
promising way to design and modify pharmaceutical 
substances. By proper adjustment of operating 
conditions (physical and chemical parameters) with 
specific crystal form can be generated, the use of SCF in 
the pharmaceutical field, which allows the significant 
industrial applications in the coming future. 
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